Literature DB >> 10919916

The prevalence of age-related maculopathy: the visual impairment project.

M R VanNewkirk1, M B Nanjan, J J Wang, P Mitchell, H R Taylor, C A McCarty.   

Abstract

PURPOSE: To determine the prevalence of age-related maculopathy (ARM) lesions in residents of the state of Victoria, Australia.
DESIGN: Population-based cross-sectional study. PARTICIPANTS: Total of 5147 residential and institutionalized persons aged 40 years and older, living in Victoria.
METHODS: Participants were recruited through a cluster, stratified, random sampling from nine urban clusters and four rural clusters. The presence of ARM lesions was graded from color stereo fundus photographs as well as slit-lamp stereo biomicroscopy according to the International Classification and Grading System. MAIN OUTCOME MEASURES: The presence of ARM lesions.
RESULTS: The mean age of participants was 60.2 years, and 55% were females. Gradable fundus photographs were available for at least one eye in 4345 (92%) of the participants. The weighted prevalence of neovascular age-related macular degeneration (AMD) was 0.39% (95% confidence limits [CL] = 0.20, 0.58), atrophic AMD was 0. 27% (95% CL = 0.04, 0.50), and total AMD was 0.68% (95% CL = 0.30, 1. 1). Prevalence of AMD was strongly related to age (P < 0.001). Prevalence of early ARM was 15.1% (95% CL = 13.7, 16.4). Large drusen, 125 micrometer or more, were present in 6.3% of the participants. There was a higher prevalence of soft distinct drusen (7.5%) than soft indistinct drusen (4.3%). Retinal pigmentary abnormalities were present in 8.2% (95% CL = 7.2, 9.2). The prevalence of large drusen, soft drusen, and pigmentary abnormalities increased with age (P < 0. 001). Prevalence of retinal pigmentary abnormalities increased with increasing drusen size (P < 0.001). Soft indistinct drusen were more common in women aged 70 years or older (P < 0.001). Bilaterality of any ARM was strongly age related, and women appeared to have a higher risk of both bilateral early ARM and AMD.
CONCLUSIONS: These data provide age- and gender-specific prevalence of ARM and its component lesions in an ethnically diverse Australian population. Early ARM and AMD prevalence rates increased sharply from ages 70 and 80 years, respectively, in all ethnic groups. These higher rates will continue to increase the importance of AMD as our population ages.

Entities:  

Mesh:

Year:  2000        PMID: 10919916     DOI: 10.1016/s0161-6420(00)00175-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  61 in total

Review 1.  World blindness: a 21st century perspective.

Authors:  H R Taylor; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  Artificial means for restoring vision.

Authors:  Parwez Hossain; Ian W Seetho; Andrew C Browning; Winfried M Amoaku
Journal:  BMJ       Date:  2005-01-01

3.  Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

Authors:  G Silvestri; M A Williams; C McAuley; K Oakes; E Sillery; D C Henderson; S Ferguson; V Silvestri; K A Muldrew
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

4.  Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life.

Authors:  Alex W Hewitt; V Swetha Jeganathan; Juanita E Kidd; Konrad Pesudovs; Nitin Verma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

Review 5.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 6.  Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis.

Authors:  Elaine W-T Chong; Tien Y Wong; Andreas J Kreis; Julie A Simpson; Robyn H Guymer
Journal:  BMJ       Date:  2007-10-08

7.  Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility.

Authors:  Xiao-Feng Hao; Li-Ke Xie; You-Zhi Tang; Wan-Kun Xie; Zhi-Fang Zhang; Yi-Xin Qi; Wen-Zheng Xiao; Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

8.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

9.  Pigment Epithelium-derived Factor Protects Retinal Pigment Epithelial Cells Against Cytotoxicity "In Vitro".

Authors:  Francisco M Nadal-Nicolas; S Patricia Becerra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

10.  Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.

Authors:  Robert F Mullins; Elizabeth A Faidley; Heather T Daggett; Catherine Jomary; Andrew J Lotery; Edwin M Stone
Journal:  Exp Eye Res       Date:  2009-07-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.